Laboratorios Farmaceuticos ROVI Strategic Asset Allocation Index
Laboratorios Farmaceuticos ROVI strategic asset allocation index. Laboratorios Farmaceuticos ROVI (ROVI) has a Strategic Asset Allocation Index of 40.9% as of September 2023. Strategic assets (PP&E of €226.66 Million plus long-term investments of €-) total €226.66 Million, measured against net assets of €554.64 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Laboratorios Farmaceuticos ROVI balance sheet independence to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Laboratorios Farmaceuticos ROVI (2003–2022)
Strategic asset allocation index of Laboratorios Farmaceuticos ROVI from 2003 to 2022. This chart shows how Laboratorios Farmaceuticos ROVI's Strategic Asset Allocation Index has evolved across 20 annual periods from 2003 to 2022. As of September 2023, the index stands at 40.9%, representing strategic assets of €226.66 Million against net assets of €554.64 Million EUR. Check tangible net worth ratio of Laboratorios Farmaceuticos ROVI to evaluate the tangible quality of the company's equity base.
Laboratorios Farmaceuticos ROVI Strategic Asset Allocation Index by Year (2003–2022)
Laboratorios Farmaceuticos ROVI strategic asset allocation index by year from 2003 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Laboratorios Farmaceuticos ROVI from 2003 to 2022, covering 20 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Laboratorios Farmaceuticos ROVI (ROVI) market capitalisation.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 41.3% | €215.54 Million | €215.54 Million | €- | €521.38 Million | ▲ +2.7 pp |
| 2021 | 38.6% | €181.78 Million | €181.78 Million | €- | €470.98 Million | ▼ -3.0 pp |
| 2020 | 41.6% | €155.40 Million | €155.40 Million | €- | €373.70 Million | ▲ +0.2 pp |
| 2019 | 41.4% | €133.52 Million | €131.61 Million | €1.91 Million | €322.39 Million | ▲ +7.3 pp |
| 2018 | 34.1% | €97.94 Million | €95.84 Million | €2.11 Million | €287.47 Million | ▼ -13.5 pp |
| 2017 | 47.6% | €91.18 Million | €89.06 Million | €2.12 Million | €191.69 Million | ▲ +1.0 pp |
| 2016 | 46.6% | €85.46 Million | €82.82 Million | €2.64 Million | €183.41 Million | ▼ -3.1 pp |
| 2015 | 49.7% | €81.87 Million | €81.80 Million | €70.00K | €164.78 Million | ▲ +3.2 pp |
| 2014 | 46.5% | €73.66 Million | €73.59 Million | €71.00K | €158.47 Million | ▼ -6.3 pp |
| 2013 | 52.8% | €76.32 Million | €60.20 Million | €16.12 Million | €144.46 Million | ▲ +10.3 pp |
| 2012 | 42.5% | €53.79 Million | €53.79 Million | €- | €126.45 Million | ▲ +2.3 pp |
| 2011 | 40.2% | €45.86 Million | €45.86 Million | €- | €113.98 Million | ▼ -0.7 pp |
| 2010 | 41.0% | €42.66 Million | €42.66 Million | €- | €104.13 Million | ▼ -4.5 pp |
| 2009 | 45.5% | €32.54 Million | €32.54 Million | €- | €71.50 Million | ▼ -16.0 pp |
| 2008 | 61.6% | €29.82 Million | €29.82 Million | €- | €48.44 Million | ▲ +20.0 pp |
| 2007 | 41.6% | €21.58 Million | €21.58 Million | €- | €51.92 Million | ▼ -12.8 pp |
| 2006 | 54.4% | €14.03 Million | €14.03 Million | €- | €25.81 Million | ▲ +54.4 pp |
| 2005 | 0.0% | €11.33 Million | €11.33 Million | €- | €4.80 Trillion | ▼ -100.9 pp |
| 2004 | 100.9% | €2.94 Million | €2.94 Million | €- | €2.92 Million | ▲ +82.9 pp |
| 2003 | 18.0% | €3.21 Million | €3.21 Million | €- | €17.80 Million | — |